CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) shares in Thousands, UYI in Thousands, $ in Thousands	Member Units Previously Reported shares	Member Units Reverse capitalization shares	Member Units Effect of reverse capitalization shares	Member Units shares	Preferred Stock Series C Previously Reported USD ($) shares	Preferred Stock Series C Reverse capitalization USD ($) shares	Common Stock Class A Common Stock USD ($) shares	Common Stock Class A Common Stock UYI shares	Common Stock Class V Common Stock USD ($) shares	Additional Paid-in Capital Reverse capitalization USD ($)	Additional Paid-in Capital Effect of reverse capitalization USD ($)	Additional Paid-in Capital USD ($)	Accumulated Deficit Previously Reported USD ($)	Accumulated Deficit Effect of reverse capitalization USD ($)	Accumulated Deficit USD ($)	Noncontrolling Interests Previously Reported USD ($)	Noncontrolling Interests USD ($)	Class A Common Stock USD ($)	Previously Reported USD ($)	Effect of reverse capitalization USD ($)	USD ($)
Balance at beginning of period at Dec. 31, 2020					$ 21,477	$ (21,477)				$ 21,477	$ 21,477		$ (184,682)	$ (184,682)					$ (163,205)	$ (163,205)
Balance at beginning of period (in shares) at Dec. 31, 2020 | shares	1,166	104,377	105,543		491	(491)
Increase (decrease) in members equity
Consolidated net loss															$ (3,910)						$ (3,910)
Equity based compensation												$ 509									509
Distributions															(81)						(81)
Balance at end of period at Mar. 31, 2021												21,986			(188,673)						(166,687)
Balance at end of period (in shares) at Mar. 31, 2021 | shares				105,543
Balance at beginning of period at Dec. 31, 2020					$ 21,477	$ (21,477)				21,477	21,477		(184,682)	(184,682)					(163,205)	(163,205)
Balance at beginning of period (in shares) at Dec. 31, 2020 | shares	1,166	104,377	105,543		491	(491)
Increase (decrease) in members equity
Consolidated net loss																					(4,480)
Balance at end of period at Jun. 30, 2021												22,452			(189,241)						(166,789)
Balance at end of period (in shares) at Jun. 30, 2021 | shares				105,543
Balance at beginning of period at Mar. 31, 2021												21,986			(188,673)						(166,687)
Balance at beginning of period (in shares) at Mar. 31, 2021 | shares				105,543
Increase (decrease) in members equity
Consolidated net loss															(568)						(568)
Equity based compensation												466									466
Balance at end of period at Jun. 30, 2021												22,452			(189,241)						(166,789)
Balance at end of period (in shares) at Jun. 30, 2021 | shares				105,543
Balance at beginning of period at Dec. 31, 2021					$ 21,477	$ (21,477)				21,477	21,477		(211,168)	(211,168)					(189,691)	(189,691)
Balance at beginning of period (in shares) at Dec. 31, 2021 | shares	1,149	103,709	104,858		491	(491)
Increase (decrease) in members equity
Consolidated net loss															(12,302)		$ (11,901)				(24,203)
Equity based compensation												402									402
Issuance of common stock upon exercise of stock option awards, net of shares withheld for income taxes												29									29
Issuance of common stock upon exercise of stock option awards, net of shares withheld for income taxes (in shares) | shares							25	25
Issuance of common stock and common stock warrants upon the reverse recapitalization, net of issuance costs							$ 4		$ 7			206,253					(64,656)				141,608
Issuance of common stock and common stock warrants upon the reverse recapitalization, net of issuance costs (in shares) | shares				(104,858)			46,832	46,832	69,781
Issuance of common stock upon exercise of warrants							$ 1					9,330									9,331
Issuance of common stock upon exercise of warrants (in shares) | UYI								UYI 5,079
Distributions															(183)						(183)
Balance at end of period at Mar. 31, 2022							$ 5		$ 7			237,433	(223,387)		(223,653)	$ (76,435)	(76,557)		(62,377)		(62,765)
Balance at end of period (in shares) at Mar. 31, 2022 | shares							51,936	51,936	69,781
Balance at beginning of period at Dec. 31, 2021					$ 21,477	$ (21,477)				$ 21,477	$ 21,477		(211,168)	$ (211,168)					(189,691)	$ (189,691)
Balance at beginning of period (in shares) at Dec. 31, 2021 | shares	1,149	103,709	104,858		491	(491)
Increase (decrease) in members equity
Consolidated net loss																			(31,063)		(29,239)
Balance at end of period at Jun. 30, 2022							$ 5		$ 7			244,799	(226,361)		(225,720)	(80,709)	(79,526)		(62,259)		(60,435)
Balance at end of period (in shares) at Jun. 30, 2022 | shares							52,448	52,448	69,781
Balance at beginning of period at Mar. 31, 2022							$ 5		$ 7			237,433	(223,387)		(223,653)	(76,435)	(76,557)		(62,377)		(62,765)
Balance at beginning of period (in shares) at Mar. 31, 2022 | shares							51,936	51,936	69,781
Increase (decrease) in members equity
Consolidated net loss															(2,067)		(2,969)		(7,248)		(5,036)
Equity based compensation												2,431									2,431
Issuance of common stock												5,000						$ 5,000			5,000
Issuance of common stock (in shares) | shares							490	490
Issuance of common stock upon exercise of stock option awards, net of shares withheld for income taxes												65									65
Issuance of common stock upon exercise of stock option awards, net of shares withheld for income taxes (in shares) | shares							22	22
Balance at end of period at Jun. 30, 2022							$ 5		$ 7			$ 244,799	$ (226,361)		$ (225,720)	$ (80,709)	$ (79,526)		$ (62,259)		$ (60,435)
Balance at end of period (in shares) at Jun. 30, 2022 | shares							52,448	52,448	69,781